— Know what they know.
Not Investment Advice
Also trades as: SLN.L (LSE) · $vol 1M · SLNCF (OTC) · $vol 0M

SLN Short Interest

Silence Therapeutics plc
1W: +1.0% 1M: +76.9% 3M: +71.3% YTD: +221.6% 1Y: +172.8% 3Y: +168.0% 5Y: -13.9%
$19.78
+0.00 (+0.00%)
After Hours: $19.48 (-0.30, -1.54%)
Weekly Expected Move ±63.8%
$-5 $7 $20 $32 $45
NASDAQ · Healthcare · Biotechnology · Tech Score Buy · Power 63 · $934.3M mcap · 38M float · 5.47% daily turnover · Short 22% of daily vol
Credit Risk of going bust: lower than 69% of companies Debt: 0.0% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.00 (down more than 99.9%), Silence Therapeutics plc would be worth roughly what it owes.
Total debt $112K against a stock market value of $934.3M.
Distance to default 7.45 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $103K (short-term plus half of long-term), stock volatility 114.2%; Altman Z'' -16.28. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.

Short Volume Summary

2026-10-26
7.1%
Short Ratio
of total volume
29.6%
20-Day Avg
34.7%
50-Day Avg
▼ Falling
5-Day Trend
0.2M
Short Volume
3.4M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 236,165 3,374,877 7.0%
NYSE 7,670 39,282 19.5%
BATS 120 985 12.2%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms